Inventor · disambiguated record
Chandrakant Dhatrak
Also filed as: DHATRAK CHANDRAKANT
15 granted patents·4 pending applications·52 citations·filing 2014–2025
90Inventor score
Top patents by PatentIndex Score
19 records- 0192US9370483B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2015·Granted Jun 21, 2016·8 cites·21 claims
- 0291US12303635B2Dispensing device and pharmaceutical composition for the treatment of rhinitisGLENMARK SPECIALTY SA·Filed 2023·Granted May 20, 2025·1 cites·10 claims
- 0391US9750754B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2016·Granted Sep 5, 2017·6 cites·51 claims
- 0490US9987260B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2017·Granted Jun 5, 2018·5 cites·39 claims
- 0590US9078923B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted Jul 14, 2015·24 cites·21 claims
- 0689US9757365B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2016·Granted Sep 12, 2017·6 cites·35 claims
- 0779US9937189B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2016·Granted Apr 10, 2018·1 cites·36 claims
- 0870US10632109B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2019·Granted Apr 28, 2020·0 cites·58 claims
- 0968US10765686B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2017·Granted Sep 8, 2020·0 cites·14 claims
- 1068US10561672B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2017·Granted Feb 18, 2020·0 cites·22 claims
- 1168US10517880B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2017·Granted Dec 31, 2019·0 cites·33 claims
- 1268US10376526B2Stable fixed dose pharmaceutical composition comprising mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2017·Granted Aug 13, 2019·0 cites·32 claims
- 1367US11679210B2Dispensing device and pharmaceutical composition for the treatment of rhinitisGLENMARK SPECIALTY SA·Filed 2018·Granted Jun 20, 2023·1 cites·16 claims
- 1467US10632108B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2018·Granted Apr 28, 2020·0 cites·20 claims
- 1564US2025242115A1Dispensing device and pharmaceutical composition for the treatment of rhinitisGLENMARK SPECIALTY SA·Filed 2025·Application pending·0 cites
- 1661US2020197370A1NANOPARTICULATE FORMULATION COMPRISING AN mPGES-1 INHIBITORGLENMARK PHARMACEUTICALS SA·Filed 2019·Application pending·0 cites
- 1755US10653683B2Tiotropium inhalation solution for nebulizationGLENMARK SPECIALTY SA·Filed 2019·Granted May 19, 2020·0 cites·71 claims
- 1839US2017135991A1NANOPARTICULATE FORMULATION COMPRISING A mPGES-1 INHIBITORGLENMARK PHARMACEUTICALS SA·Filed 2015·Application pending·0 cites
- 1938US2018133151A1Nebulized tiotropiumGLENMARK SPECIALTY SA·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chandrakant Dhatrak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →